Temasek-backed entity to acquire 16% stake in Ayala’s healthcare arm

[BENGALURU] AC Health, the healthcare arm of the Philippines’ oldest conglomerate Ayala, said on Monday (Aug 11) that a private equity firm backed by Singapore’s state-investor Temasek will acquire a 16 per cent minority stake in the company.

In August 2024, Reuters reported that Ayala was keen on selling a minority stake in its healthcare business, which would value the company at up to US$500 million.

AC Health did not specify a value for the 16 per cent stake.

Global investors are increasingly drawn to South-east Asia’s healthcare sector, wagering on the region’s rising prosperity, ageing demographics, and the industry’s resilience in a challenging economic climate.

In November 2023, Malaysian conglomerate Sime Darby and Australia’s Ramsay Health Care agreed to sell their equal ownership joint venture for RM5.7 billion (S$1.7 billion).

Established in 2015, AC Health has expanded its portfolio to include the Generika and St Joseph Drug pharmacy chains, as well as pharmaceutical importer and distributor IE Medica and MedEthix, according to its websites.

SEE ALSO

Temasek sees 10 times gain with 5.5 billion euro stake sale in Indian JV with Schneider

Temasek to buy 5% stake in Ermenegildo Zegna 

Temasek proposes 5-year, 10-year and 30-year tranches of offshore Chinese yuan bonds

Temasek unit Azalea is back with another PE-based bond offering – Astrea 9

More

Asean Intelligence

Get insights into businesses across South-east Asia

Get the free report

It aims to expand its network to at least 10 hospitals, 300 clinics and 1,150 pharmacies. REUTERS